Linda Farkas, MD
Colon & Rectal Surgery · Chesapeake, VANPI 1558334730
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $6,105 and has fallen 88.4% since, to $710 in 2025.
Across 41 payments — averaging $267.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Merck$3K
- Medtronic$577
- Myriad Genetic Laboratories, Inc.$252
- Johnson & Johnson$166
- Sirtex Medical Inc$139
- plus $352 from 8 others
What the payments were for
- Consulting fees$2,50023%
- Travel & lodging$4474%
- Food & beverage$2,00918%
- Education$6,00055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $6,969 |
| Merck | 1 | $2,500 |
| Medtronic | 14 | $577 |
| Myriad Genetic Laboratories, Inc. | 2 | $252 |
| Johnson & Johnson | 2 | $166 |
| Sirtex Medical Inc | 1 | $139 |
| Covidien LP | 1 | $109 |
| Axonics, Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| TELA Bio, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Innovation Technologies Inc | 1 | $16 |
| THD America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- Da Vinci Surgical System$713
- myRisk$252
- Enseal X1$150
- VISTASEAL$150
- Harmonic$150
- SIR-Spheres Microspheres$139
- TA$124
- EEA$117
- Axonics$105
How this compares
$10,956 in reported general payments places this provider in the 85th percentile of 46 colon & rectal surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 14 | $77 |
| Metronidazole | 16 | $51 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Chesapeake
- Brian BuchbergChesapeake$459
- Andrew VorenbergRichmond$560K
- Craig RezacArlington$33K
- Kimberly MatzieFairfax$28K
- Rodolfo PigalargaArlington$24K
- Gregory FitzharrisHampton$22K
- Ayana Chase-GreavesFredericksburg$11K
- Emily RivetRichmond$5K
- Jaime BohlRichmond$5K
- Zachary GreggCharlottesville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.